Patents by Inventor Ana Catarina PARENTE PEREIRA PURI

Ana Catarina PARENTE PEREIRA PURI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11566222
    Abstract: A method for expanding a population of ?? T-cells is provided in which isolated activated Peripheral Blood Mononuclear Cells (PBMCs) are cultured in a medium comprising transforming growth factor beta (TGF-?) under conditions in which the production of effector ?? T-cells having therapeutic activity against malignant disease is favored. The use of TGF-? in the production of effector cells in particular V?9V?2 T-cells is also described and claimed.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: January 31, 2023
    Assignee: KING'S COLLEGE LONDON
    Inventors: John Maher, Ana Catarina Parente Pereira Puri, Richard Esmond Beatson
  • Publication number: 20200140816
    Abstract: A method for expanding a population of ?? T-cells is provided in which isolated activated Peripheral Blood Mononuclear Cells (PBMCs) are cultured in a medium comprising transforming growth factor beta (TGF-?) under conditions in which the production of effector ?? T-cells having therapeutic activity against malignant disease is favored. The use of TGF-? in the production of effector cells in particular V?9V?2 T-cells is also described and claimed.
    Type: Application
    Filed: December 18, 2019
    Publication date: May 7, 2020
    Inventors: John MAHER, Ana Catarina PARENTE PEREIRA PURI, Richard Esmond BEATSON
  • Publication number: 20200123502
    Abstract: A method for expanding a population of ?? T-cells is provided in which isolated activated Peripheral Blood Mononuclear Cells (PBMCs) are cultured in a medium comprising transforming growth factor beta (TGF-?) under conditions in which the production of effector ?? T-cells having therapeutic activity against malignant disease is favored. The use of TGF-? in the production of effector cells in particular V?9V?2 T-cells is also described and claimed.
    Type: Application
    Filed: December 18, 2019
    Publication date: April 23, 2020
    Inventors: John MAHER, Ana Catarina PARENTE PEREIRA PURI, Richard Esmond BEATSON
  • Patent number: 10557117
    Abstract: A method for expanding a population of ?? T-cells is provided in which isolated activated Peripheral Blood Mononuclear Cells (PBMCs) are cultured in a medium comprising transforming growth factor beta (TGF-?) under conditions in which the production of effector ?? T-cells having therapeutic activity against malignant disease is favored. The use of TGF-? in the production of effector cells in particular V?9V?2 T-cells is also described and claimed.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: February 11, 2020
    Assignee: King's College London
    Inventors: John Maher, Ana Catarina Parente Pereira Puri, Richard Esmond Beatson
  • Publication number: 20170342381
    Abstract: A method for expanding a population of ?? T-cells is provided in which isolated activated Peripheral Blood Mononuclear Cells (PBMCs) are cultured in a medium comprising transforming growth factor beta (TGF-?) under conditions in which the production of effector ?? T-cells having therapeutic activity against malignant disease is favored. The use of TGF-? in the production of effector cells in particular V?9V?2 T-cells is also described and claimed.
    Type: Application
    Filed: December 4, 2015
    Publication date: November 30, 2017
    Inventors: John MAHER, Ana Catarina PARENTE PEREIRA PURI, Richard Esmond BEATSON